Effects of probenecid on the elicitation of spreading depression in the rat striatum

Brain Research

Volumn 764, Issue 1-2, 1997, Pages 117-125

  Taylor, Deanna L ^a,c   Urenjak, Jutta ^b   Zilkha, Elias ^a   Obrenovitch, Tihomir P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

DC potential; Kynurenic acid; Lactate; Microdialysis; N Methyl D aspartate; Organic anion transport; Probenecid; Spreading depression

Indexed keywords

KYNURENIC ACID; PROBENECID;

ACIDIFICATION; ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROENCEPHALOGRAPHY; HOMEOSTASIS; MIGRAINE; NERVE INJURY; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION; VISUAL CORTEX;

ANIMALS; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; HYDROGEN-ION CONCENTRATION; KYNURENIC ACID; LACTIC ACID; MALE; MICRODIALYSIS; NEOSTRIATUM; POTASSIUM; PROBENECID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPREADING CORTICAL DEPRESSION; URICOSURIC AGENTS;

EID: 0030769795     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00434-4     Document Type: Article

References (64)

1. T. Akiyama, M. Sato, S. Otsuki, Probenecid-induced convulsion and cerebrospinal cyclic nucleotides in the kindling cat preparations, Brain Nerve (Tokyo) 33 (1981) 1107-1113.
2. P. Andine, A. Lehmann, K. Ellren, E. Wennberg, I. Kjellmer, T. Nielsen, H. Hagberg, The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection, Neurosci. Lett. 90 (1988) 208-212.
3. T. Back, M.D. Ginsberg, W.D. Dietrich, B.D. Watson, induction of spreading depression in the ischemic hemisphere following experimental middle cerebral-artery occlusion - effect on infarct morphology, J. Cereb. Blood Flow Metab. 16 (1996) 202-213.
4. H. Benveniste, P.C. Hüttemeier, Microdialysis - theory and application, Prog. Neurobiol. 35 (1990) 195-215.
5. P. Birch, C.J. Grossman, A.G. Hayes, Kynurenate and FG9041 have both competitive and non-competitive actions at excitatory amino acid receptors, Eur. J. Pharmacol. 151 (1988) 313-315.
6. P. Birch, C.J. Grossman, A.G. Hayes, Kynurenic acid antagonizes responses to NMDA via an action at the strychnine-insensitive glycine receptor, Eur. J. Pharmacol. 154 (1988) 85-87.
7. J. Bures, O. Buresova, J. Krivanek, The Mechanisms and Applications of Leao's Spreading Depression of Electroencephalographic Activity, Academic Press, New York, 1974.
8. A.J. Carter, Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination, J. Pharmacol. Exp. Ther. 269 (1994) 573-580.
9. R.F. Cunningham, Z.J. Israili, P.G. Dayton, Clinical pharmacokinetics of probenecid, Clin. Pharmacokin. 6 (1981) 135-151.
10. P.G. Dayton, T.F. Yu, W. Chen, L. Berger, L.A. West, A.B. Gutman, The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material, J. Pharmacol. Exp. Ther. 140 (1963) 278-286.
11. B.-M. Emanuelsson, L.K. Paalzow, Dose-dependent pharmacokinetics of probenecid in the rat, Biopharmacol. Drug Dispos. 9 (1988) 59-70.
12. A.S. Fix, G.G. Long, D.F. Wozniak, J.W. Olney, Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: a review, Drug Dev. Res. 32 (1994) 147-152.
13. A.C. Foster, A. Vezzani, E.D. French, R. Schwarcz, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett. 90 (1984) 208-212.
14. A.R. Gardner-Medwin, Possible roles of vertebrate neuroglia in potassium dynamics, spreading depression and migraine, J. Exp. Biol. 95 (1981) 111-127.
15. I.M. Germano, L.H. Pitts, B.S. Meldrum, H.M. Bartowski, R.P. Simon, Kynurenate inhibition of excitation decreases stroke size and deficits, Ann. Neurol. 22 (1987) 730-734.
16. R.J. Hargreaves, M. Rigby, D. Smith, R.G. Hill, Lack of effect of L-687,414 (( + )-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology, Br. J. Pharmacol. 110 (1993) 36-42.
17. O. Herreras, G.G. Somjen, Propagation of spreading depression among dendrites and somata of the same cell population, Brain Res. 610 (1993) 276-282.
18. R.R. Hicks, D.H. Smith, T.A. Gennarelli, T. McIntosh, Kynurenate is neuroprotective following experimental brain injury in the rat, Brain Res. 655 (1994) 91-96.
19. T. lijima, G. Mies, K.-A. Hossmann, Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury, J. Cereb. Blood Flow Metab. 12 (1992) 727-733.
20. J. Kehr, A survey on quantitative microdialysis: theoretical models and practical implications, J. Neurosci. Methods 48 (1993) 251-261.
21. J.A. Kemp, P.D. Leeson, The glycine site of the NMDA receptor -five years on, Trends Neurosci. 14 (1993) 20-25.
22. M. Kessler, T. Terramani, G. Lynch, M. Baudry, A glycine site associated with N-methyl-D-aspartatic acid receptors: characterization and identification of a new class of antagonists, J. Neurochem. 52 (1989) 1319-1328.
23. W. Koek, F.C. Colpaert, Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects, J. Pharmacol. Exp. Ther. 252 (1990) 349-357.
24. V.I. Koroleva, J. Bures, Rats do not experience cortical or hippocampal spreading depression as aversive, Neurosci. Lett. 149 (1993) 153-156.
25. J. Kravzov, A. Santamaria, C. Rios, A. Flores, M. Altagracia, Protective effect of probenecid on circling behavior of rats with unilateral quinolinic acid induced striatal lesions, Proc. West Pharmacol. Soc. 36 (1993) 255-257.
26. W.G. Kuhr, J. Korf, Extracellular lactic acid as an indicator of brain metabolism: continuous on-line measurement in conscious, freely moving rats with intrastriatal dialysis, J. Cereb. Blood Flow Metab. 8 (1988) 130-137.
27. W.G. Kuhr, C.J. Van den Berg, J. Korf, In vivo identification and quantitative evaluation of carrier-mediated transport of lactate at the cellular level in the striatum of conscious, freely moving rats, J. Cereb. Blood Flow Metab. 8 (1988) 848-856.
28. C. Largo, P. Cuevas, G.G. Somjen, R.M. Delrio, O. Herreras, The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival, J. Neurosci. 16 (1996) 1219-1229.
29. K.S. Lashley, Patterns of cerebral integration indicated by the scotomas of migraine, Arch. Neurol. Psychiatry 46 (1941) 331-339.
30. M. Lauritzen, Pathophysiology of the migraine aura: the spreading depression theory, Brain 117 (1994) 199-210.
31. M. Lauritzen, A.J. Hansen, The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression, J. Cereb. Blood Flow Metab. 12 (1992) 223-229.
32. A.A.P. Leao, Spreading depression of activity in the cerebral cortex, J. Neurophysiol. 7 (1944) 359-390.
33. V. MacMillan, Effect of probenecid on cerebral and cisternal cerebrospinal fluid lactate content, J. Cereb. Blood Flow Metab. 7 (1987) 118-123.
34. 2 and hyperventilation on spreading depression in the rat, Arch. Int. Physiol. Biochim. Biophys. 94 (1985) P19-P20.
35. S.E. McKinney, H.M. Peck, J.M. Bockey, B.B. Byham, G.S. Schucharadt, K.H. Beyer, Benemid, p-(di-n-propyl-sulfamyl)-benzoic acid: toxicologic properties, J. Pharmacol. Exp. Ther. 102 (1951) 208-214.
36. J.M. Miller, U. MacGarvey, M.F. Beal, The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations, Neurosci. Lett. 146 (1992) 115-118.
37. F. Moroni, P. Russi, G. Lombardi, M. Beni, V. Carla, Presence of kynurenic acid in the mammalian brain, J. Neurochem. 51 (1988) 177-180.
38. K. Nozaki, M.F. Beal, Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats, J. Cereb. Blood Flow Metab. 12 (1992) 400-407.
39. T.P. Obrenovitch, The ischaemic penumbra: twenty years on, Cerebrovasc. Brain Metab. Rev. 7 (1995) 297-323.
40. T.P. Obrenovitch, D.A. Richards, G.S. Sarna, L. Symon, Combined intracerebral microdialysis and electrophysiological recording: methodology and applications, J. Neurosci. Methods 47 (1993) 139-145.
41. T.P. Obrenovitch, J. Urenjak, E. Zilkha, Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo, Br. J. Pharmacol. 113 (1994) 1295-1302.
42. T.P. Obrenovitch, E. Zilkha, Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex, Br. J. Pharmacol. 117 (1996) 931-937.
43. T.P. Obrenovitch, E. Zilkha, J. Urenjak, Evidence against high extracellular glutamate promoting the elicitation of spreading depression, J. Cereb. Blood Flow Metab. 16 (1996) 923-931.
44. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, London, 1986.
45. R.D. Piper, G.A. Lambert, J. Michalicek, Inhalational anesthetic agents decrease susceptibility to cortical spreading depression in the cat, Soc. Neurosci. Abstr. 17 (1991) 339.
46. B.-E. Roos, G. Wickström, P. Hartvig, J.L.G. Nilsson, Quantitation of CSF concentrations and biological activity of probenecid metabolites, Eur. J. Clin. Pharmacol. 17 (1980) 223-226.
47. P. Russi, M. Alesiani, G. Lombardi, P. Davolio, R. Pellicciari, F. Moroni, Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions, J. Neurochem. 59 (1992) 2076-2080.
48. R. Saito, R. Graf, G. Rosner, K. Hubel, T. Taguchi, W.-D. Heiss, Anesthesia affects potassium evoked spreading depression in cats, J. Cereb. Blood Flow Metab. 13 (Suppl. 1) (1993) S86.
49. D. Scheller, J. Kolb, The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples, J. Neurosci. Methods 40 (1991) 31-38.
50. M.J. Sheardown, The triggering of spreading depression in the chicken retina: a pharmacological study, Brain Res. 607 (1993) 189-194.
51. A.D. Smith, J.B. Justice, The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine, J. Neurosci. Methods 54 (1994) 75-82.
52. M. Sramka, G. Brozek, J. Bures, P. Nadvornik, Functional ablation by spreading depression: possible use in human stereotactic neurosurgery, Appl. Neurophysiol. 40 (1977/8) 48-61.
53. K.J. Swartz, M.J. During, A. Freese, M.F. Beal, Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors, J. Neurosci. 10 (1990) 2965-2973.
54. J.C. Szerb, Glutamate release and spreading depression in the fascia dentata in response to microdialysis with high K: role of glia, Brain Res. 542 (1991) 259-265.
55. D.L. Taylor, T.P. Obrenovitch, L. Symon, Changes in extracellular acid-base homeostasis in cerebral ischemia, Neurochem. Res. 21 (1996) 1013-1021.
56. +-induced depolarisation in the rat striatum, J. Neurochem. 62 (1994) 2368-2374.
57. S.F. Traynelis, S. Cull-Candy, Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons, Nature 345 (1990) 347-350.
58. J. Urenjak, T.P. Obrenovitch, E. Zilkha, Effect of probenecid on N-methyl-D-aspartate (NMDA) induced depolarizations in the rat striatum, Naunyn-Schmiedeberg's Arch. Pharmacol. 355 (1997) 36-42.
59. J. Urenjak, E. Zilkha, M. Gotoh, T.P. Obrenovitch, Effect of acidotic challenges on local depolarizations evoked by N-methyl-D-aspartate (NMDA) in the rat striatum, Life Sci. (1997) (in press).
60. L. Vecsei, J. Miller, U. MacGarvey, M.F. Beal, Effects of kynurenine and probenecid on plasma and brain tissue concentrations of kynurenic acid, Neurodegeneration 1 (1992) 17-26.
61. L. Vecsei, J. Miller, U. MacGarvey, M.F. Beal, Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain, Brain Res. Bull. 26 (1992) 233-238.
62. M. Verhaegen, M.M. Todd, D.S. Warner, The influence of different concentrations of volatile anesthetics on the threshold for cortical spreading depression in rats, Brain Res. 581 (1992) 153-155.
63. F. Wahl, T.P. Obrenovitch, A.M. Hardy, M. Plotkine, R. Boulu, L. Symon, Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium-dependency, J. Neurochem. 63 (1994) 1003-1011.
64. J. Willetts, R.L. Balster, J.D. Leander, The behavioral pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci. 11 (1990) 423-428.